Latest Drugs, Latest Approval in Miscellaneous cardiovascular agents

What are Miscellaneous cardiovascular agents?

Miscellaneous cardiovascular agents are drugs, which are used to treat conditions of the heart, or the circulatory or vascular system. Many classes of cardiovascular agents are available to treat the various cardiovascular conditions. They may work by different mechanisms and one agent may be used to treat several types of cardiovascular problems.

Name Updated
Sparsentan (Sparsentan [ spar-sen-tan ]) 29-Aug-2023
Metyrosine (Metyrosine [ me-tye-roe-seen ]) 17-Aug-2023
Mavacamten (Mavacamten [ mav-a-kam-ten ]) 16-Aug-2023
Sotagliflozin (Sotagliflozin [ soe-ta-gli-floe-zin ]) 15-Aug-2023
Phenoxybenzamine (Phenoxybenzamine [ fen-ox-ee-benz-a-meen ]) 14-Aug-2023
Midodrine (Midodrine [ my-doe-drin ]) 13-Aug-2023
Cilostazol (Cilostazol [ sye-loe-sta-zol ]) 11-Aug-2023
Oraverse (Phentolamine mesylate) 05-Aug-2023
Pletal (Cilostazol [ sye-loe-sta-zol ]) 13-Jul-2023
Inpefa (Sotagliflozin) 13-Jul-2023
Filspari (Sparsentan) 13-Jul-2023
Dibenzyline (Phenoxybenzamine [ fen-ox-ee-benz-a-meen ]) 13-Jul-2023
Demser (Metyrosine [ me-tye-roe-seen ]) 13-Jul-2023
Corlanor (Ivabradine [ eye-vab-ra-deen ]) 13-Jul-2023
Camzyos (Mavacamten) 13-Jul-2023
Ivabradine (Ivabradine [ eye-vab-ra-deen ]) 10-Jul-2023